Literature DB >> 9737494

Absolute lymphocyte count as a predictor of CD4 count.

N I Shapiro1, D J Karras, S H Leech, K L Heilpern.   

Abstract

STUDY
OBJECTIVE: To determine whether the absolute lymphocyte count (ALC) (white blood count x lymphocyte percentage) can be used to predict a low CD4 count.
METHODS: We conducted a retrospective data analysis of consecutive CD4 count analyses performed between January 1, 1995, through December 1, 1995, at an urban university teaching hospital. Results of consecutive CD4 counts and simultaneously measured ALCs were analyzed from samples obtained in inpatient, clinic, and emergency department settings. The ability of ALC to predict a CD4 count less than 200 cells/mm3 was analyzed by calculating sensitivities, specificities, predictive values, and likelihood ratios for a range of ALC values.
RESULTS: Among the 807 samples, 322 results (40%) had a CD4 count less than 200 cells/mm3. The ALC and CD4 count were correlated (r=.69, P<.0001). An ALC less than 1,000 cells/mm3 predicted CD4 counts less than 200 cells/mm3 with a sensitivity of .67 (95% confidence interval .62 to .72), specificity of .96 (.94 to .98), positive predictive value of .91 (.87 to .95), and a negative predictive value of .81 (.78 to .84). An ALC less than 2,000 cells/mm3 predicted CD4 counts less than 200 cells/mm3 with a sensitivity of .97 (.95 to .99), specificity of .41 (.37 to .45), positive predictive value of .52 (.48 to .56), and negative predictive value of .95 (.92 to .98).
CONCLUSION: A reliable relationship exists between ALC and CD4 count. In a similar population, an ALC less than 1,000 cells/mm3 is predictive of a CD4 count less than 200 cells/mm3, and an ALC greater than or equal to 2,000 cells/mm3 is predictive of a CD4 count greater than or equal to 200 cells/mm3. Physicians may find these criteria useful in identifying patients with increased risk of opportunistic infection.

Entities:  

Mesh:

Year:  1998        PMID: 9737494     DOI: 10.1016/s0196-0644(98)70008-3

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  6 in total

1.  Covariate random effects on the CD4 count variation during HIV disease progression in women.

Authors:  Partson Tinarwo; Temesgen Zewotir; Delia North
Journal:  HIV AIDS (Auckl)       Date:  2019-05-20

2.  An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa.

Authors:  Partson Tinarwo; Temesgen Zewotir; Nonhlanhla Yende-Zuma; Nigel J Garrett; Delia North
Journal:  Infect Dis Ther       Date:  2019-02-12

3.  Acute Pneumocystis jirovecii Pneumonia Due to Absolute Lymphopenia.

Authors:  Eric Hilker; Sachin M Patil; Rodger Wilhite; Zach Holliday
Journal:  Cureus       Date:  2022-03-02

4.  Factors Associated With Candidiasis in Systemic Lupus Erythematosus Patients in Cipto Mangunkusumo National General Hospital: A Single-Center Case-Control Study.

Authors:  Ivan Damara; Kevin Winston; Frisky Maulida; Anna Ariane
Journal:  Cureus       Date:  2022-07-21

5.  A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases.

Authors:  Catherine S Forconi; Cliff I Oduor; Peter O Oluoch; John M Ong'echa; Christian Münz; Jeffrey A Bailey; Ann M Moormann
Journal:  Front Cell Infect Microbiol       Date:  2020-04-21       Impact factor: 5.293

6.  Trends and Adaptive Optimal Set Points of CD4+ Count Clinical Covariates at Each Phase of the HIV Disease Progression.

Authors:  Partson Tinarwo; Temesgen Zewotir; Delia North
Journal:  AIDS Res Treat       Date:  2020-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.